Loading organizations...
Loading organizations...
Biotechnology company focused on cell therapy research and development.
Innovative Cellular Therapeutics has raised $75.2M across 2 funding rounds.
Innovative Cellular Therapeutics has raised $75.2M in total across 2 funding rounds.
Innovative Cellular Therapeutics has raised $75.2M in total across 2 funding rounds.
Innovative Cellular Therapeutics's investors include GTJA Investment Group, （刘缨） Helena Liu, Suyang Zhang.
Innovative Cellular Therapeutics has raised $75.2M across 2 funding rounds. Most recently, it raised $50.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 2, 2022 | $50.0M Series A | ||
| Apr 24, 2018 | $25.2M Other Equity | GTJA Investment Group, （刘缨） Helena Liu, Suyang Zhang |